Your browser doesn't support javascript.
loading
STANDARD TREATMENT WITH BEVACIZUMAB AS TARGETED THERAPY IN CERVICAL CANCER.
Enríquez-Aceves, Isabel; Galicia-Carmona, Tatiana; Coronel-Martínez, Jaime A; Espinosa-Romero, Raquel; Calderillo-Ruíz, Germán; Cortés-Esteban, Patricia; Cetina-Pérez, Lucely.
Affiliation
  • Enríquez-Aceves I; Department of Medical Oncology, Hospital del Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), León, Gto., Mexico.
  • Galicia-Carmona T; Department of Clinical Research and Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Coronel-Martínez JA; Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Espinosa-Romero R; Department of Clinical Research and Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Calderillo-Ruíz G; Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Cortés-Esteban P; Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Cetina-Pérez L; Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico.
Rev Invest Clin ; 72(4): 213-218, 2020.
Article in En | MEDLINE | ID: mdl-33064702
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Bevacizumab Type of study: Prognostic_studies Limits: Female / Humans Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Bevacizumab Type of study: Prognostic_studies Limits: Female / Humans Language: En Year: 2020 Type: Article